These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 19034331)

  • 21. Serum neutrophil gelatinase-associated lipocalin is associated with cardiovascular events in patients with chronic kidney disease.
    Solak Y; Yilmaz MI; Siriopol D; Saglam M; Unal HU; Yaman H; Gok M; Cetinkaya H; Gaipov A; Eyileten T; Sari S; Yildirim AO; Tonbul HZ; Turk S; Covic A; Kanbay M
    Int Urol Nephrol; 2015 Dec; 47(12):1993-2001. PubMed ID: 26498629
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiovascular outcomes and all-cause mortality: exploring the interaction between CKD and cardiovascular disease.
    Weiner DE; Tabatabai S; Tighiouart H; Elsayed E; Bansal N; Griffith J; Salem DN; Levey AS; Sarnak MJ
    Am J Kidney Dis; 2006 Sep; 48(3):392-401. PubMed ID: 16931212
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship of phosphorus and calcium-phosphorus product with mortality in CKD.
    Menon V; Greene T; Pereira AA; Wang X; Beck GJ; Kusek JW; Collins AJ; Levey AS; Sarnak MJ
    Am J Kidney Dis; 2005 Sep; 46(3):455-63. PubMed ID: 16129207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxidative stress, inflammation and cardiovascular mortality in haemodialysis--role of seniority and intravenous ferrotherapy: analysis at 4 years of follow-up.
    Bayés B; Pastor MC; Bonal J; Foraster A; Romero R
    Nephrol Dial Transplant; 2006 Apr; 21(4):984-90. PubMed ID: 16326744
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p-Cresol and cardiovascular risk in mild-to-moderate kidney disease.
    Meijers BK; Claes K; Bammens B; de Loor H; Viaene L; Verbeke K; Kuypers D; Vanrenterghem Y; Evenepoel P
    Clin J Am Soc Nephrol; 2010 Jul; 5(7):1182-9. PubMed ID: 20430946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. C-reactive protein as a predictor of cardiovascular events in elderly patients with chronic kidney disease.
    Jalal D; Chonchol M; Etgen T; Sander D
    J Nephrol; 2012; 25(5):719-25. PubMed ID: 22038335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors of fatal and nonfatal cardiovascular events in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia: an analysis of the Trial to Reduce cardiovascular Events with Aranesp (darbepoetin-alfa) Therapy (TREAT).
    McMurray JJ; Uno H; Jarolim P; Desai AS; de Zeeuw D; Eckardt KU; Ivanovich P; Levey AS; Lewis EF; McGill JB; Parfrey P; Parving HH; Toto RM; Solomon SD; Pfeffer MA
    Am Heart J; 2011 Oct; 162(4):748-755.e3. PubMed ID: 21982669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum Trimethylamine-N-Oxide Is Strongly Related to Renal Function and Predicts Outcome in Chronic Kidney Disease.
    Missailidis C; Hällqvist J; Qureshi AR; Barany P; Heimbürger O; Lindholm B; Stenvinkel P; Bergman P
    PLoS One; 2016; 11(1):e0141738. PubMed ID: 26751065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emerging cardiovascular risk factors that account for a significant portion of attributable mortality risk in chronic kidney disease.
    Shishehbor MH; Oliveira LP; Lauer MS; Sprecher DL; Wolski K; Cho L; Hoogwerf BJ; Hazen SL
    Am J Cardiol; 2008 Jun; 101(12):1741-6. PubMed ID: 18549850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma high-sensitivity troponin T predicts end-stage renal disease and cardiovascular and all-cause mortality in patients with type 1 diabetes and diabetic nephropathy.
    Galsgaard J; Persson F; Hansen TW; Jorsal A; Tarnow L; Parving HH; Rossing P
    Kidney Int; 2017 Nov; 92(5):1242-1248. PubMed ID: 28712855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decoy receptor 3, a novel inflammatory marker, and mortality in hemodialysis patients.
    Hung SC; Hsu TW; Lin YP; Tarng DC
    Clin J Am Soc Nephrol; 2012 Aug; 7(8):1257-65. PubMed ID: 22626963
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum adiponectin and cardiovascular risk in chronic kidney disease and kidney transplantation.
    Chitalia N; Raja RB; Bhandara T; Agrawal P; Kaski JC; Jha V; Banerjee D
    J Nephrol; 2010; 23(1):77-84. PubMed ID: 20091490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early markers of cardiovascular risk in chronic kidney disease.
    Lai S; Dimko M; Galani A; Coppola B; Innico G; Frassetti N; Mazzei ED; Mariotti A
    Ren Fail; 2015 Mar; 37(2):254-61. PubMed ID: 25394527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ventricular function and all-cause mortality in chronic kidney disease patients with angiographic coronary artery disease.
    Wu IW; Hung MJ; Chen YC; Hsu HJ; Cherng WJ; Chang CJ; Wu MS
    J Nephrol; 2010; 23(2):181-8. PubMed ID: 20119930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ankle brachial index as a predictor for mortality in patients with chronic kidney disease and undergoing haemodialysis.
    Chen SC; Chang JM; Hwang SJ; Tsai JC; Liu WC; Wang CS; Lin TH; Su HM; Chen HC
    Nephrology (Carlton); 2010 Apr; 15(3):294-9. PubMed ID: 20470297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis.
    deFilippi C; Wasserman S; Rosanio S; Tiblier E; Sperger H; Tocchi M; Christenson R; Uretsky B; Smiley M; Gold J; Muniz H; Badalamenti J; Herzog C; Henrich W
    JAMA; 2003 Jul; 290(3):353-9. PubMed ID: 12865376
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relevance of uric acid and asymmetric dimethylarginine for modeling cardiovascular risk prediction in chronic kidney disease patients.
    Kanbay M; Afsar B; Siriopol D; Unal HU; Karaman M; Saglam M; Eyileten T; Gezer M; Verim S; Oguz Y; Vural A; Ortiz A; Johnson RJ; Covic A; Yilmaz MI
    Int Urol Nephrol; 2016 Jul; 48(7):1129-36. PubMed ID: 27007614
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors.
    Shlipak MG; Fried LF; Cushman M; Manolio TA; Peterson D; Stehman-Breen C; Bleyer A; Newman A; Siscovick D; Psaty B
    JAMA; 2005 Apr; 293(14):1737-45. PubMed ID: 15827312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relation of baseline presence and severity of renal disease to long-term mortality in persons with known stroke.
    Ani C; Ovbiagele B
    J Neurol Sci; 2010 Jan; 288(1-2):123-8. PubMed ID: 19853862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The relationship between nontraditional risk factors and outcomes in individuals with stage 3 to 4 CKD.
    Weiner DE; Tighiouart H; Elsayed EF; Griffith JL; Salem DN; Levey AS; Sarnak MJ
    Am J Kidney Dis; 2008 Feb; 51(2):212-23. PubMed ID: 18215699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.